Paul D Brown MD
Benign Diseases, Central Nervous System Cancer, Skin Cancer
Professor
Join to View Full Profile
200 1st St SW# MayoRochester, MN 55905
Phone+1 507-284-2511
Dr. Brown is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Paul Brown is a radiation oncologist in Rochester, MN and is affiliated with Mayo Clinic Hospital - Rochester. He has been in practice 19 years. He specializes in brain metastases and benign diseases and is experienced in primary brain tumors.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Radiation Oncology, 1996 - 2000- Mayo Clinic College of Medicine and Science (Rochester)Internship, Internal Medicine, 1995 - 1996
University of North Dakota School of Medicine and Health SciencesClass of 1995
Certifications & Licensure
MT State Medical License 2020 - 2028
TX State Medical License 2010 - 2027
MN State Medical License 1996 - 2026
WY State Medical License 1999 - 2026
MI State Medical License 2020 - 2023
WI State Medical License 2004 - 2013
FL State Medical License 2001 - 2011
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013-2015, 2017
- CMS Meaningful Use Stage 2 Certification Mayo Clinic Incorporate Lab Results, Mayo Clinic, 2013-2015, 2017
- CMS Meaningful Use Stage 2 Certification Mayo Clinic Patient Lists, Mayo Clinic, 2013-2015, 2017
Clinical Trials
- Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System Start of enrollment: 2004 Jan 01
- Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2006 May 01
- Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Start of enrollment: 2006 Jul 01
Publications & Presentations
PubMed
- Risks associated with ventriculomegaly and symptomatic communicating hydrocephalus following stereotactic radiosurgery for vestibular schwannoma.Megan M J Bauman, Samantha M Bouchal, Ramin A Morshed, Jamie J Van Gompel, Maria Peris Celda
Journal of Neurosurgery. 2026-05-01 - 3 citationsTreatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical Trial.Ayal A Aizer, Kee-Young Shin, Paul J Catalano, Ivy Ricca, Marciana Johnson
JAMA. 2026-04-07 - 1 citationsLong-term tumor control after Gamma Knife radiosurgery for sporadic vestibular schwannoma.John P Marinelli, Ghazal S Daher, Karl R Khandalavala, Eric E Babajanian, James R Dornhoffer
Journal of Neurosurgery. 2026-04-01
Journal Articles
- Brain Metastases: Fractionated Whole-Brain RadiotherapyPaul Brown, MD, ScienceDirect
- Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported OutcomesKevin S Roof, Paul D Brown, Samuel T Chao, William A Hall, Minesh P Mehta, Benjamin Movsas, Jeffrey S Wefel, Neurosurgery
Press Mentions
Radiotherapy for Brain Metastases: ASTRO Updates GuidelinesJune 10th, 2022- New Guideline Provides Guidance on the Use of Radiation Therapy to Treat Patients with Brain MetastasesMay 10th, 2022
- Avoiding Hippocampus in Brain RT May Help Preserve Cognitive FunctionAugust 13th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
